Genome-Guided Discovery of Floridanemastatin, a Statine-Containing Polyketide-Peptide from the Cyanobacterium Floridanema evergladense
Journal of Natural Products · 2026
DOI: 10.1021/acs.jnatprod.6c00987 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Natural Products, 2026. Verfasst von Aaditi Chopade und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Case Western Reserve University, Cleveland, Ohio44106, United States. Hauptthemen laut MEDLINE: Cyanobacteria, Polyketides, Peptides. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, National Institute of Food and Agriculture, National Institute of Environmental Health Sciences.
Abstract (Originalsprache)
We report the genome-guided discovery, isolation, and characterization of floridanemastatin (1), a previously undescribed statine-containing polyketide−peptide from Floridanema evergladense BLCC-F167. Examination of the biosynthetic gene clusters in the F.evergladense genome revealed a hybrid PKS−NRPS biosynthetic gene cluster featuring an NRPS module followed by a PKS ketoextension and ketoreductase domain arrangement diagnostic of statine biosynthesis. Guided by this prediction, LC−MS-based analysis of cultured biomass led to the isolation of floridanemastatin. High-resolution mass spectrometry and comprehensive 1D and 2D NMR spectroscopy defined a polyketide−peptide scaffold incorporating serine, proline, a leucine-derived amino alcohol, and a statine-like residue identified as 4-amino-3-hydroxy-(4-hydroxyphenyl)pentanoic acid. Connectivity and residue assignments were consistent with the predicted biosynthetic logic of the gene cluster, including reductive chain termination to yield an alcohol. Although the statine pharmacophore and in silico target prediction suggested cathepsin D as a plausible target, enzymatic evaluation indicated that apparent inhibition was attributable to nonspecific aggregation under the assay conditions. These findings demonstrate the utility of biosynthetic gene cluster architecture for prospecting statine-containing cyanobacterial natural products and further highlights the genus Floridanema as a source of chemically distinctive specialized metabolites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Case Western Reserve University, Cleveland, Ohio44106, United States.
- Fort Lauderdale Research and Education Center, University of FloridaInstitute of Food and Agricultural Sciences, Davie, Florida33314, United States.
ORCID-Profile: H Dail Laughinghouse, Matthew J Bertin
Förderung
- NIEHS NIH HHS
- National Institute of Food and Agriculture
- National Institute of Environmental Health Sciences
Zitieren
APA
Chopade, A., Meinardus, T., Berthold, D. E., Lefler, F. W., Laughinghouse, H. D., & Bertin, M. J. (2026). Genome-Guided Discovery of Floridanemastatin, a Statine-Containing Polyketide-Peptide from the Cyanobacterium Floridanema evergladense. Journal of Natural Products. https://doi.org/10.1021/acs.jnatprod.6c00987
Vancouver
Chopade A, Meinardus T, Berthold DE, Lefler FW, Laughinghouse HD, Bertin MJ. Genome-Guided Discovery of Floridanemastatin, a Statine-Containing Polyketide-Peptide from the Cyanobacterium Floridanema evergladense. Journal of Natural Products. 2026. doi:10.1021/acs.jnatprod.6c00987
BibTeX
@article{Chopade2026,
author = {Chopade, Aaditi and Meinardus, Terrance and Berthold, David E and Lefler, Forrest W and Laughinghouse, H Dail and Bertin, Matthew J},
title = {Genome-Guided Discovery of Floridanemastatin, a Statine-Containing Polyketide-Peptide from the Cyanobacterium Floridanema evergladense},
journal = {Journal of Natural Products},
year = {2026},
doi = {10.1021/acs.jnatprod.6c00987}
}
EUVIMED